IRBESARTAN | A202910 | HETERO LABS LTD UNIT V
Highest NADAC/Unit
$0.1647
per ea
Lowest NADAC/Unit
$0.0843
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722073190IRBESARTAN 300 MG TABLET | $0.1647 | EA | Generic | — | 2026-10-21 |
| 31722073130IRBESARTAN 300 MG TABLET | $0.1647 | EA | Generic | — | 2026-10-21 |
| 31722073105IRBESARTAN 300 MG TABLET | $0.1647 | EA | Generic | — | 2026-10-21 |
| 31722073090IRBESARTAN 150 MG TABLET | $0.1090 | EA | Generic | — | 2026-10-21 |
| 31722073005IRBESARTAN 150 MG TABLET | $0.1090 | EA | Generic | — | 2026-10-21 |
| 31722073030IRBESARTAN 150 MG TABLET | $0.1090 | EA | Generic | — | 2026-10-21 |
| 31722072930IRBESARTAN 75 MG TABLET | $0.0843 | EA | Generic | — | 2026-10-21 |
| 31722072990IRBESARTAN 75 MG TABLET | $0.0843 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.